Report #2828872

Overview

Sex

Female

Age

Age unknown

State

—

Recovered

Not recovered

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (2)

Symptom narrative

Guilluan barre syndrome; This serious case was reported by a consumer via interactive digital media and described the occurrence of guillain barre syndrome in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced guillain barre syndrome (Verbatim: Guilluan barre syndrome) (serious criteria death and GSK medically significant). The patient died in 2024. The reported cause of death was guillain barre syndrome. It was unknown if the reporter considered the guillain barre syndrome to be related to Shingrix. The company considered the guillain barre syndrome to be unrelated to Shingrix. Additional Information: GSK Receipt Date: 25-FEB-2025 The case was received from the patient's husband via interactive digital media. The patient got 2 Shingrix shingles shots and died last summer from Guillain Barre syndrome. The reporter stated that it would of been better off with shingles.; Sender's Comments: Guillain-Barre syndrome is an unlisted event which is considered unrelated to GSK vaccine Shingrix.; Reported Cause(s) of Death: Guillain Barre syndrome